Avid Bioservices to be Acquired by GHO Capital Partners and Ampersand Capital Partners in $1.1 Billion Transaction
Portfolio Pulse from
Avid Bioservices, Inc. (NASDAQ: CDMO) is set to be acquired by GHO Capital Partners and Ampersand Capital Partners in an all-cash transaction valued at approximately $1.1 billion.
November 06, 2024 | 11:30 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Avid Bioservices is being acquired by GHO Capital Partners and Ampersand Capital Partners for $1.1 billion in an all-cash transaction.
The acquisition of Avid Bioservices by GHO Capital Partners and Ampersand Capital Partners is a significant event for the company, likely leading to a positive short-term impact on its stock price due to the premium typically associated with acquisition offers.
CONFIDENCE 100
IMPORTANCE 90
RELEVANCE 100